Source: Pharamceutical Technology

Goldfinch Bio: Karuna signs license deal with Goldfinch Bio for TRPC4/5 candidates

Karuna will have exclusive rights to develop, manufacture and market Goldfinch Bio's TRPC4/5 candidates. The post Karuna signs license deal with Goldfinch Bio for TRPC4/5 candidates appeared first on Pharmaceutical Technology.

Read full article »
Goldfinch Bio's Competitors | Goldfinch Bio's News | Goldfinch Bio's Financials
Stay up-to-date with the latest news on Goldfinch Bio
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Anthony Johnson's photo - President & CEO of Goldfinch Bio

President & CEO

Anthony Johnson

CEO Approval Rating

94/100

Read more
Stay up-to-date with the latest news on Goldfinch Bio